Systemic treatment of brain metastases in HER2-positive breast cancer: current status and future directions
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic treatment of brain metastases in HER2-positive breast cancer: current status and future directions
Authors
Keywords
-
Journal
Future Oncology
Volume 8, Issue 2, Pages 135-144
Publisher
Future Medicine Ltd
Online
2012-02-16
DOI
10.2217/fon.11.149
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breast Cancer Resistance Protein and P-Glycoprotein in Brain Cancer: Two Gatekeepers Team Up
- (2012) Sagar Agarwal et al. CURRENT PHARMACEUTICAL DESIGN
- Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of death
- (2011) Romuald Le Scodan et al. BMC CANCER
- Central Nervous System Metastases in Patients with HER2-Positive Metastatic Breast Cancer: Incidence, Treatment, and Survival in Patients from registHER
- (2011) A. M. Brufsky et al. CLINICAL CANCER RESEARCH
- Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases
- (2011) Nancy U. Lin et al. JOURNAL OF NEURO-ONCOLOGY
- Monoclonal antibodies in neuro-oncology
- (2011) Lois A. Lampson mAbs
- Management of Patients with Brain Metastases Receiving Trastuzumab Treatment for Metastatic Breast Cancer
- (2011) Isabell Witzel et al. ONKOLOGIE
- The Phosphodiesterase-5 Inhibitor Vardenafil Is a Potent Inhibitor of ABCB1/P-Glycoprotein Transporter
- (2011) Pei-Rong Ding et al. PLoS One
- Trastuzumab in the Adjuvant Treatment of HER2-Positive Early Breast Cancer Patients: A Meta-Analysis of Published Randomized Controlled Trials
- (2011) Wenjin Yin et al. PLoS One
- Extended Survival in Women With Brain Metastases From HER2 Overexpressing Breast Cancer
- (2010) David N. Church et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine
- (2010) G. Metro et al. ANNALS OF ONCOLOGY
- Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases – the UK experience
- (2010) S Sutherland et al. BRITISH JOURNAL OF CANCER
- Prognostic factors of survival in the trastuzumab era among women with breast cancer and brain metastases who receive whole brain radiotherapy
- (2010) Shaheenah Dawood et al. CANCER
- Multifactorial central nervous system recurrence susceptibility in patients with HER2-positive breast cancer
- (2010) Antonino Musolino et al. CANCER
- Heterogeneous Blood-Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer
- (2010) P. R. Lockman et al. CLINICAL CANCER RESEARCH
- Preliminary Results of Whole Brain Radiotherapy With Concurrent Trastuzumab for Treatment of Brain Metastases in Breast Cancer Patients
- (2010) Cyrus Chargari et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast Cancer
- (2010) Kimberly L. Blackwell et al. JOURNAL OF CLINICAL ONCOLOGY
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- Phosphodiesterase Type 5 Inhibitors Increase Herceptin Transport and Treatment Efficacy in Mouse Metastatic Brain Tumor Models
- (2010) Jinwei Hu et al. PLoS One
- Brain Metastases
- (2010) Francois Kamar et al. SEMINARS IN NEUROLOGY
- Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study
- (2009) S. Siena et al. ANNALS OF ONCOLOGY
- Role of efflux pump activity in lapatinib/caelyx combination in breast cancer cell lines
- (2009) Ivan Vannini et al. ANTI-CANCER DRUGS
- Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but notHER2/neu-positive breast cancer
- (2009) Kan Yonemori et al. CANCER
- A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen
- (2009) Paul Ruff et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer
- (2009) N. U. Lin et al. CLINICAL CANCER RESEARCH
- Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Central Nervous System Metastases
- (2009) Brian Leyland-Jones JOURNAL OF CLINICAL ONCOLOGY
- The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
- (2009) Minesh P. Mehta et al. JOURNAL OF NEURO-ONCOLOGY
- International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy
- (2009) Fatima Cardoso et al. JNCI-Journal of the National Cancer Institute
- CXCR4 Expression in Early Breast Cancer and Risk of Distant Recurrence
- (2009) F. Andre et al. ONCOLOGIST
- Uptake of ANG1005, A Novel Paclitaxel Derivative, Through the Blood-Brain Barrier into Brain and Experimental Brain Metastases of Breast Cancer
- (2009) Fancy C. Thomas et al. PHARMACEUTICAL RESEARCH
- Trastuzumab treatment beyond brain progression in HER2-positive metastatic breast cancer
- (2008) I. H. Park et al. ANNALS OF ONCOLOGY
- Defining prognosis for women with breast cancer and CNS metastases by HER2 status
- (2008) S. Dawood et al. ANNALS OF ONCOLOGY
- PDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor model
- (2008) Keith L. Black et al. BRAIN RESEARCH
- A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses
- (2008) David Cameron et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases
- (2008) Raffaele Addeo et al. CANCER
- Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2
- (2008) C.-l. Dai et al. CANCER RESEARCH
- Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain
- (2008) Cimona V. Hinton et al. CLINICAL & EXPERIMENTAL METASTASIS
- Phase II Trial of Lapatinib for Brain Metastases in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- (2008) Nancy U. Lin et al. JOURNAL OF CLINICAL ONCOLOGY
- Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector Angiopep-2
- (2008) Michel Demeule et al. JOURNAL OF NEUROCHEMISTRY
- Effect of Lapatinib on the Outgrowth of Metastatic Breast Cancer Cells to the Brain
- (2008) B. Gril et al. JNCI-Journal of the National Cancer Institute
- Targeting Her-2/neu in Breast Cancer: As Easy as This!
- (2008) Hamdy Azim et al. ONCOLOGY
- LDL Receptor-Related Protein 1: Unique Tissue-Specific Functions Revealed by Selective Gene Knockout Studies
- (2008) Anna P. Lillis et al. PHYSIOLOGICAL REVIEWS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started